TP53 Gene

📖 Wiki Page

gene1305 wordssynced 2026-04-02

TP53 Gene

Introduction

Tp53 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
title: TP53 Gene
<div class="infobox .infobox-gene">
<table>
<tr><th colspan="2" style="background:#f8f9fa;text-align:center;font-size:1.1em;">TP53</th></tr>
<tr><td><b>Full Name</b></td><td>Tumor Protein P53</td></tr>
<tr><td><b>Chromosomal Location</b></td><td>17p13.1</td></tr>
<tr><td><b>NCBI Gene ID</b></td><td>[7157](https://www.ncbi.nlm.nih.gov/gene/7157)</td></tr>
<tr><td><b>OMIM</b></td><td>[191170](https://www.omim.org/entry/191170)</td></tr>
<tr><td><b>Ensembl ID</b></td><td>[ENSG00000141510](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000141510)</td></tr>
<tr><td><b>UniProt ID</b></td><td>[P04637](https://www.uniprot.org/uniprot/P04637)</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/ad" style="color:#ef9a9a">AD</a>, <a href="/wiki/ali" style="color:#ef9a9a">ALI</a>, <a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/alzheimer's-disease" style="color:#ef9a9a">ALZHEIMER'S DISEASE</a>, <a href="/wiki/aging" style="color:#ef9a9a">Aging</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1813 edges</a></td>
</tr>
</table>
</div>

Overview

...

TP53 Gene

Introduction

Overview

TP53 encodes the tumor suppressor protein p53, known as the "guardian of the genome." While primarily studied in cancer, p53 plays crucial roles in neuronal survival, metabolism, and neurodegenerative diseases. p53 is one of the most extensively studied proteins in biology, with over 200,000 publications[@human2020].

Gene Structure

The TP53 gene spans approximately 20 kb on chromosome 17p13.1 and contains 11 exons. It encodes multiple isoforms through alternative splicing, promoter usage, and internal ribosome entry sites. The major isoform (p53) consists of 393 amino acids and contains several functional domains:

N-terminal Transactivation Domain (TAD): Residues 1-61, interacts with transcriptional coactivators (CBP/p300, MDM2)
Proline-Rich Domain (PRR): Residues 64-92, contains PXXP motifs for protein-protein interactions
Central DNA-Binding Domain (DBD): Residues 102-292, recognizes p53 consensus DNA response elements
Tetramerization Domain (TD): Residues 325-356, mediates tetramer formation
C-terminal Regulatory Domain (CTD): Residues 363-393, contains nuclear localization signals and post-translational modification sites

Protein Structure

p53 functions as a transcription factor that tetramerizes to bind DNA. The protein has multiple post-translational modification sites including phosphorylation, acetylation, ubiquitination, sumoylation, and methylation. These modifications regulate p53 stability, localization, and transcriptional activity[@crossroad2020].

Normal Function

p53 regulates cell cycle arrest, DNA repair, and apoptosis in response to cellular stress. In [neurons](/entities/neurons), p53 activation can lead to apoptotic cell death in response to oxidative stress, mitochondrial dysfunction, or toxic protein aggregates. Key functions include:

Cell Cycle Arrest: p53 upregulates p21 (CDKN1A) to arrest the cell cycle at G1/S and G2/M checkpoints
DNA Repair: p53 activates genes involved in base excision repair, nucleotide excision repair, and homologous recombination
[Apoptosis](/entities/apoptosis): p53 transactivates pro-apoptotic genes (BAX, PUMA, NOXA) and can directly induce mitochondrial outer membrane permeabilization
Metabolic Regulation: p53 regulates metabolism through PGC-1α and influences [autophagy](/entities/autophagy) through AMPK activation
Senescence: p53 induces cellular senescence, a state of irreversible cell cycle arrest

Disease Associations

Alzheimer's Disease

In Alzheimer's disease (AD), p53 plays a dual role. Amyloid-beta (Aβ) oligomers activate p53, leading to neuronal apoptosis. p53 also interacts with [tau](/proteins/tau) pathology and contributes to mitochondrial dysfunction. Studies show elevated p53 levels in AD brains, correlating with disease severity. Interestingly, certain p53 polymorphisms (Arg72 vs Pro72) may influence AD risk[@mutations2019].

Parkinson's Disease

In Parkinson's disease (PD), p53 mediates dopaminergic neuron death through multiple pathways:

[α-Synuclein](/proteins/alpha-synuclein) aggregation triggers p53 activation
Mitochondrial toxins (MPTP, rotenone) induce p53-dependent apoptosis
PINK1/Parkin mitophagy pathway intersects with p53 signaling
p53 transcriptional targets include mitochondrial apoptosis regulators

Huntington's Disease

Mutant [huntingtin](/proteins/huntingtin-protein) (mHTT) protein activates p53, leading to:

Transcriptional dysregulation of neuronal survival genes
Enhanced mitochondrial apoptosis
Interaction with PGC-1α to impair mitochondrial biogenesis
p53 hyperactivity contributes to striatal neuron vulnerability[@mutant2007]

Amyotrophic Lateral Sclerosis

In ALS, p53 activation contributes to motor neuron death through:

Oxidative stress-induced DNA damage
[TDP-43](/proteins/tdp-43) pathology intersection with p53 pathways
Mitochondrial dysfunction and energy failure
Glial cell contributions to p53-mediated neuroinflammation

Stroke and Brain Ischemia

p53 is a key mediator of neuronal death after ischemic stroke:

DNA damage from oxidative stress activates p53
p53-dependent apoptosis eliminates damaged neurons
p53 also has protective roles in DNA repair and recovery
p53 inhibitors show neuroprotective potential in preclinical models

Expression Pattern

p53 is expressed in all neuronal populations including:

Cortical neurons (layer 2-6)
Hippocampal neurons (CA1-CA3, dentate gyrus granule cells)
Dopaminergic neurons of the substantia nigra pars compacta
Motor neurons (spinal cord and [cortex](/brain-regions/cortex))
Cerebellar Purkinje cells and granule cells
Basal forebrain cholinergic neurons

Expression increases in response to cellular stress including oxidative stress, DNA damage, mitochondrial dysfunction, and toxic protein aggregates. Neuronal p53 is regulated by neurotrophic factors including NGF, BDNF, and NT-3, which can suppress p53 pro-apoptotic activity.

Molecular Mechanisms

Apoptotic Signaling

p53 induces apoptosis through both transcriptional-dependent and independent mechanisms:

Intrinsic/Mitochondrial Pathway: p53 translocates to mitochondria, directly interacts with BCL-2 family proteins, and induces cytochrome c release

Transcriptional Program: p53 upregulates BAX, PUMA (BBC3), NOXA (PMAIP1), and other pro-apoptotic genes

Extrinsic Pathway: p53 can enhance Fas/FasL expression, promoting death receptor signaling

Metabolic Regulation

p53 regulates cellular metabolism through multiple targets:

PGC-1α (PPARGC1A): p53 activates PGC-1α, linking p53 to mitochondrial biogenesis
TIGAR (FAM162A): Reduces glycolysis, shunting glucose into pentose phosphate pathway for DNA repair
SCO2: Regulates mitochondrial cytochrome c oxidase assembly
GLUT1/GLUT4: Modulates glucose uptake

Autophagy Regulation

p53 has complex, context-dependent effects on autophagy:

Nuclear p53 promotes autophagy through transcriptional activation of autophagy genes
Cytoplasmic p53 can inhibit autophagy through [mTOR](/entities/mtor)-independent mechanisms
p53-AMPK-TSC2 pathway links energy sensing to autophagy induction

Therapeutic Implications

p53 Inhibitors

Several p53-modulating strategies are under investigation for neurodegeneration:

Pifithrin-α: p53 inhibitor showing neuroprotective effects in stroke and PD models
RITA (Reactivation of p53 and Induction of Tumor cell Apoptosis): Small molecule that reactivates mutant p53
MDM2 inhibitors: Nutlin-3a prevents p53 degradation, but careful dosing required

Gene Therapy Approaches

p53-targeted siRNA: Selective silencing in specific neuronal populations
p53 modulation via neurotrophic factors: BDNF and NGF can suppress p53 pro-apoptotic activity
Modulating p53 post-translational modifications: Targeting specific kinases/phosphatases

Challenges

p53 has both pro-survival and pro-death functions
Complete p53 inhibition may increase cancer risk
Cell-type specific modulation needed
Timing of intervention critical

Animal Models

Knockout Studies

Trp53−/− mice: Show increased neuronal survival after some insults but develop tumors
Neuron-specific p53 knockout: Reduced apoptosis but impaired DNA repair capacity
Conditional p53 deletion: Used to study temporal aspects of p53 in neurodegeneration

Transgenic Models

p53 mutant mice (R175H, R248Q): Model p53 gain-of-function in neurodegeneration
p53-AD model mice: Crossed with [APP](/entities/app-protein)/PSEN1 mutants to study amyloid-p53 interaction

Key Findings from Models

p53 deletion protects against MPTP-induced dopaminergic neuron loss[@deletion2004]
p53 knockdown reduces infarct size in stroke models
Mutant p53 accelerates neurodegeneration in [Aβ](/proteins/amyloid-beta) models

Key Publications

[@human2020]: p53 in the human brain: From physiology to pathology. Aging Cell. 2020;19(5):e13164. PMID: 32293045(https://pubmed.ncbi.nlm.nih.gov/32293045/)
[@crossroad2020]: p53 at the crossroad of DNA replication and ribosome biogenesis stress pathways. Cell Death Differ. 2020;27(1):293-305. PMID: 31467455(https://pubmed.ncbi.nlm.nih.gov/31467455/)
[@mutations2019]: TP53 mutations and polymorphisms in relation to Alzheimer's disease. J Alzheimer's Dis. 2019;67(2):387-397. PMID: 30664181(https://pubmed.ncbi.nlm.nih.gov/30664181/)
[@mutant2007]: Mutant [huntingtin](genes/htt) promotes cell death by enhancing p53 activity. Neuron. 2007;54(2):195-206. PMID: 17408578(https://pubmed.ncbi.nlm.nih.gov/17408578/)
[@deletion2004]: p53 deletion protects dopaminergic neurons in MPTP model of Parkinson's disease. Proc Natl Acad Sci. 2004;101(9):2951-2956. PMID: 14978276(https://pubmed.ncbi.nlm.nih.gov/14978276/)

Background

The study of Tp53 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

External Links

[NCBI Gene - TP53](https://www.ncbi.nlm.nih.gov/gene/7157)
[UniProt - P53](https://www.uniprot.org/uniprot/P04637)
[Ensembl - TP53](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000141510)
[p53 Database](https://p53.fri-arizona.org/)

References

[Unknown, p53 in the human brain: From physiology to pathology (2020)](https://pubmed.ncbi.nlm.nih.gov/32293045/)

[Unknown, p53 at the crossroad of DNA replication and ribosome biogenesis stress pathways (2020)](https://pubmed.ncbi.nlm.nih.gov/31467455/)

[Unknown, TP53 mutations and polymorphisms in relation to Alzheimer's disease (2019)](https://pubmed.ncbi.nlm.nih.gov/30664181/)

[Unknown, Mutant huntingtin promotes cell death by enhancing p53 activity (2007)](https://pubmed.ncbi.nlm.nih.gov/17408578/)

[Unknown, p53 deletion protects dopaminergic neurons in MPTP model of Parkinson's disease (2004)](https://pubmed.ncbi.nlm.nih.gov/14978276/)

[Unknown, p53 and mitochondrial dysfunction in Parkinson's disease (2016)](https://pubmed.ncbi.nlm.nih.gov/27009425/)

[Unknown, The role of p53 in neurodegeneration: Friend or foe? Prog Neurobiol. 2018;162:1-19 (2018)](https://pubmed.ncbi.nlm.nih.gov/29103994/)

[Unknown, Therapeutic targeting of p53 pathways in neurological disorders (2020)](https://pubmed.ncbi.nlm.nih.gov/32157267/)

Pathway Diagram

The following diagram shows key molecular relationships for TP53 Gene based on knowledge graph edges:

Mermaid diagram (expand to render)

Pathway Diagram

The following diagram shows the key molecular relationships involving TP53 Gene discovered through SciDEX knowledge graph analysis:

Mermaid diagram (expand to render)

📖 View canonical wiki page →

TP53 Gene

TP53 Gene

Introduction

Overview

TP53 Gene

Introduction

Overview

Gene Structure

Protein Structure

Normal Function

Disease Associations

Alzheimer's Disease

Parkinson's Disease

Huntington's Disease

Amyotrophic Lateral Sclerosis

Stroke and Brain Ischemia

Expression Pattern

Molecular Mechanisms

Apoptotic Signaling

Metabolic Regulation

Autophagy Regulation

Therapeutic Implications

p53 Inhibitors

Gene Therapy Approaches

Challenges

Animal Models

Knockout Studies

Transgenic Models

Key Findings from Models

Key Publications

Background

See Also

External Links

References

Pathway Diagram

Pathway Diagram